Hildur Helgadottir

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Topics

Top Venues

Acta oncologica (Stockholm, Sweden)

Cancer research communications

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Ellen Backlund, Vitali Grozman, Suzanne Egyhazi Brage, Rolf Lewensohn, Karin Lindberg, Hildur Helgadottir
Radiotherapy with or without immunotherapy in metastatic melanoma: efficacy and Tolerability. Acta oncologica (Stockholm, Sweden) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Vasu R Sah, Henrik Jespersen, Joakim Karlsson, Lisa M Nilsson, Mattias Bergqvist, Iva Johansson, Ana Carneiro, Hildur Helgadottir, Max Levin, Gustav J Ullenhag, Anders Ståhlberg, Roger Olofsson Bagge, Jonas Andreas Nilsson, Lars Ny
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy. Cancer research communications 3 (5) (2023)
Hildur Helgadottir, Karina Schultz, Jan Lapins, Ismini Vassilaki, Charlotta All-Eriksson, Veronica Höiom
BAP1 genetic testing among melanoma and cancer-prone families in Sweden. Acta oncologica (Stockholm, Sweden) (2023)
Michael R Sargen, Hildur Helgadottir, Xiaohong R Yang, Mark Harland, Jessica N Hatton, Kristine Jones, Belynda D Hicks, Amy A Hutchinson, Michael Curry, Margaret A Tucker, Alisa M Goldstein, Ruth M Pfeiffer
Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers. JNCI cancer spectrum 6 (6) (2022)
Fernanda Costa Svedman, Marie Jalsenius, Vitali Grozman, Mattias Bergqvist, Fabian Söderdahl, Samuel Rotstein, Lars Ny, Suzanne Egyhazi Brage, Hildur Helgadottir
Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy. Acta oncologica (Stockholm, Sweden) 61 (9) (2022)
Maria Pissa, Jan Lapins, Christina Sköldmark, Hildur Helgadottir
Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Esteban Astiazaran-Symonds, Cole Graham, Jung Kim, Margaret A Tucker, Christian Ingvar, Hildur Helgadottir, Lorenza Pastorino, Remco van Doorn, Joshua N Sampson, Bin Zhu, William Bruno, Paola Queirolo, Giuseppe Fornarini, Stefania Sciallero, Brian Carter, Belynda D Hicks, Amy A Hutchinson, Kristine Jones, Douglas R Stewart, Stephen J Chanock, Neal D Freedman, Maria Teresa Landi, Veronica Höiom, Susana Puig Sardà, Nelleke A Gruis, Xiaohong R Yang, Paola Ghiorzo, Alisa M Goldstein
Gene-Level Associations in Patients With and Without Pathogenic Germline Variants in CDKN2A and Pancreatic Cancer. JCO precision oncology 6 (2022)
Maria Pissa, Teo Helkkula, Frida Appelqvist, Gustav Silander, Åke Borg, Jenny Pettersson, Jan Lapins, Kari Nielsen, Veronica Höiom, Hildur Helgadottir
CDKN2A genetic testing in melanoma-prone families in Sweden in the years 2015-2020: implications for novel national recommendations. Acta oncologica (Stockholm, Sweden) 60 (7) (2021)
Francesco Spagnolo, Bruna Dalmasso, Enrica Tanda, Miriam Potrony, Susana Puig Sardà, Remco van Doorn, Ellen H W Kapiteijn, Paola Queirolo, Hildur Helgadottir, Paola Ghiorzo
Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants. Cancers 13 (10) (2021)
Carl-Jacob Holmberg, Dimitrios Katsarelias, Henrik Jespersen, Ana Carneiro, Nils O Elander, Hildur Helgadottir, Karolin Isaksson, Malin Jansson, Sara Wirén, Gustav J Ullenhag, Lars Ny, Roger Olofsson Bagge
Surgery of metastatic melanoma after systemic therapy - the SUMMIST trial: study protocol for a randomized controlled trial. Acta oncologica (Stockholm, Sweden) 60 (1) (2020)